Alnylam Pharmaceuticals (NASDAQ:ALNY) reported its Q1 earnings results on Thursday, April 28, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Alnylam Pharmaceuticals beat estimated earnings by 19.02%, reporting an EPS of $-1.49 versus an estimate of $-1.84.
Revenue was up $35.69 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.15 which was followed by a 0.07% drop in the share price the next day.
Here's a look at Alnylam Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.54 | -1.57 | -1.6 | -1.75 |
| EPS Actual | -1.69 | -1.51 | -1.3 | -1.64 |
| Revenue Estimate | 233.62M | 218.69M | 193.18M | 168.74M |
| Revenue Actual | 258.54M | 187.63M | 220.55M | 177.57M |
To track all earnings releases for Alnylam Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
